Our site may be slower due to heavy traffic from automated "bots" and AI crawlers. We're working to fix this.

Amirali Salmasi

Photo of Amirali Salmasi
Title(s)Associate Clinical Professor, Urology
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Overview 

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Comprehensive Comparison of Somatic, Germline, and Immune Cell Profiles in Upper Tract and Bladder Urothelial Carcinoma. JCO Precis Oncol. 2025 Aug; 9:e2500289. Yuen K, Meagher M, Mercer J, Yilma B, Stoppler M, Fragkogianni S, Mar N, Kalebasty AR, Gupta S, Grivas P, Bagrodia A, Mckay R, Stewart T, Salmasi A. PMID: 40773709.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    2. Metabolic Syndrome Among Testicular Cancer Survivors: Long-Term Follow-Up of the Veterans Affairs Health System. Cancer Med. 2025 Apr; 14(8):e70858. Puri D, Riviere P, Meagher M, Morgan K, Nelson T, Yuen K, Pandit K, Yodkhunnatham N, Taylor J, Herchenhorn D, Stewart T, Javier-Desloges J, Salmasi A, McKay RR, Kern SQ, Hofflich H, Millard F, Rose B, Bagrodia A. PMID: 40256970; PMCID: PMC12010195.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    3. Osteoporosis Amongst Testicular Cancer Survivors: Long Term Follow-Up of the Veterans Affairs Health System. Clin Genitourin Cancer. 2025 Jun; 23(3):102332. Yodkhunnatham N, Riviere P, Pandit K, Morgan K, Meagher M, Dabbas M, Nelson T, Puri D, Yuen K, Taylor J, Herchenhorn D, Hofflich H, Stewart T, Javier-Desloges J, Salmasi A, McKay RR, Kern SQ, Millard F, Rose B, Bagrodia A. PMID: 40203524.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Natural History of subcentimeter pulmonary nodules in clinical stage I seminoma patients. Urol Oncol. 2025 04; 43(4):272.e11-272.e15. Yodkhunnatham N, Puri D, Pandit K, Leonard A, Dolendo I, Langner J, Roberts J, Cortes J, Meagher M, Salmasi A, Mckay RR, Rose B, Millard FE, Bagrodia A. PMID: 40000359.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Germline genetic testing for prostate cancer: Ordering trends in the era of expanded hereditary cancer screening recommendations. Urol Oncol. 2025 03; 43(3):195.e21-195.e27. Roberts JL, Wang LL, Rose B, Seibert TM, Madlensky L, Nielsen SM, Salmasi A, Kader AK, Kane CJ, Crawford ED, Javier-Desloges J, McKay RR, Bagrodia A. PMID: 39482144.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Patterns of Failure After Definitive Trimodality Therapy for Muscle-Invasive Bladder Cancer. Clin Genitourin Cancer. 2025 Feb; 23(1):102229. Kotha NV, Kumar A, Riviere P, Nelson TJ, Qiao EM, Salmasi A, McKay RR, Efstathiou JA, Rose BS, Stewart TF. PMID: 39709685.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Prostate-Specific Antigen and Prostate Cancer in Gender-Affirming Hormone Therapy for Transgender or Nonbinary Individuals. Int J Radiat Oncol Biol Phys. 2025 Mar 01; 121(3):761-767. Morgan KM, Deshler LN, Tibbs MD, Qiao EM, Anger JT, Salmasi A, Marshall DC, Sanghvi P, Rose BS, Riviere P. PMID: 39357786.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Incidence of Erectile Dysfunction and Testosterone Deficiency in Testicular Cancer Survivors. J Urol. 2025 Jan; 213(1):71-79. Pandit K, Riviere P, Morgan K, Nelson T, Meagher M, Puri D, Yodkhunnatham N, Deshler L, Duran E, Sabater-Minarim D, Javier-Desloges J, Salmasi A, McKay RR, Millard F, Hsieh TC, Patel DP, Rose BS, Bagrodia A. PMID: 39348687.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    9. Cancer-Associated Venous Thromboembolic Disease, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2024 09; 22(7):483-506. Streiff MB, Holmstrom B, Angelini D, Ashrani A, Buckner T, Diep R, Fertrin KY, Fogerty AE, Crestani NG, Gangaraju R, Rojas-Hernandez C, Goldhaber SZ, Ibrahim I, Kubal T, Leavitt AD, Lim M, Mann J, Mantha S, Morton C, Nester A, O'Brien A, Ortel TL, Pine A, Pishko A, Ranade M, Salmasi A, Schaefer J, Williams E, Wool G, Wun T, Montgomery S, Nguyen J, Freedman-Cass D, Sliker B. PMID: 39236759.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    10. Oncological and Survival Outcomes of Pelvic Lymph Node Dissection in Patients with Nonmuscle Invasive Bladder Cancer Undergoing Radical Cystectomy Using the National Cancer Database. Clin Genitourin Cancer. 2024 Dec; 22(6):102197. Moldovan M, Nam P, Satpathy Y, Wang L, Bagrodia A, Salmasi A, Stewart TF, Derweesh I, Javier-DesLoges J. PMID: 39260096.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    11. Prostate cancer in transgender women: A propensity score-matched analysis of disease severity and survival. Cancer. 2024 Nov 15; 130(22):3863-3869. Meagher M, Morgan K, Deshler L, Riviere P, Dolendo I, Rose B, Jamieson C, Morris S, Nik-Ahd F, Freedland S, Anger J, Salmasi A. PMID: 39033478.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    12. Characterization and impact of non-canonical WNT signaling on outcomes of urothelial carcinoma. Cancer Med. 2024 Apr; 13(7):e7148. Meagher M, Krause H, Elliott A, Farrell A, Antonarakis ES, Bastos B, Heath EI, Jamieson C, Stewart TF, Bagrodia A, Nabhan C, Oberley M, McKay RR, Salmasi A. PMID: 38558536; PMCID: PMC10983807.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    13. Robot-assisted laparoscopic nephrectomy: early outcome measures with the implementation of multimodal analgesia and intrathecal morphine via the acute pain service. World J Urol. 2024 Mar 04; 42(1):117. Meineke MN, Losli MV, Sztain JF, Swisher MW, Abramson WB, Martin EI, Furnish TJ, Salmasi A, Derweesh IH, Gabriel RA, Said ET. PMID: 38436828; PMCID: PMC10912429.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    14. The Role of Radical Cystectomy in Clinically Node Positive Bladder Cancer: A US Veterans Health Administration Study. Clin Genitourin Cancer. 2024 Jun; 22(3):102055. Meagher M, Morgan KM, Deshler L, Puri D, Yuen K, Bagrodia A, Rose B, Stewart T, Salmasi A. PMID: 38458889.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Treatment Landscape for Metastatic Castrate-Sensitive Prostate Cancer: A Review. Res Rep Urol. 2023; 15:509-517. Meagher MF, Salmasi A, Stewart TF. PMID: 38025805; PMCID: PMC10655601.
      View in: PubMed   Mentions: 3  
    16. The Current and Future Promises of Combination Radiation and Immunotherapy for Genitourinary Cancers. Cancers (Basel). 2022 Dec 25; 15(1). Saidian A, Dolendo I, Sharabi A, Stewart TF, Rose B, McKay RR, Bagrodia A, Salmasi A. PMID: 36612124; PMCID: PMC9818005.
      View in: PubMed   Mentions: 3  
    17. RE: Cancer Stage, Treatment, and Survival Among Transgender Patients in the United States. J Natl Cancer Inst. 2022 08 08; 114(8):1203-1204. Javier-DesLoges J, Salmasi A, Jamieson CA, Anger JT. PMID: 35191502; PMCID: PMC9360451.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    18. Prostate cancer multiparametric magnetic resonance imaging visibility is a tumor-intrinsic phenomena. J Hematol Oncol. 2022 05 03; 15(1):48. Khoo A, Liu LY, Sadun TY, Salmasi A, Pooli A, Felker E, Houlahan KE, Ignatchenko V, Raman SS, Sisk AE, Reiter RE, Boutros PC, Kislinger T. PMID: 35505417; PMCID: PMC9066728.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    19. Implementing Continuous Quality Improvement in an Integrated Community Urology Practice: Lessons Learned. Urology. 2021 07; 153:139-146. Gaylis F, Nasseri R, Salmasi A, Anderson C, Mohedin S, Prime R, Swift S, Dato P, Cohen E, Catalona W, Topp R, Friedman L, Kane C. PMID: 33482125.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    20. Positive surgical margins at radical prostatectomy in the United States: Institutional variations and predictive factors. Urol Oncol. 2020 01; 38(1):1.e17-1.e23. Pooli A, Salmasi A, Johnson DC, Lenis AT, Faiena I, Lebacle C, Golla V, Drakaki A, Gollapudi K, Blumberg J, Pantuck AJ, Chamie K. PMID: 31537483.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    21. Cytoreductive nephrectomy in patients with metastatic renal cell carcinoma and venous thrombus-Trends and effect on overall survival. Urol Oncol. 2019 09; 37(9):577.e9-577.e16. Lenis AT, Burton CS, Golla V, Pooli A, Faiena I, Johnson DC, Salmasi A, Drakaki A, Gollapudi K, Blumberg J, Pantuck AJ, Chamie K. PMID: 30930099; PMCID: PMC6698401.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    22. Molecular Hallmarks of Multiparametric Magnetic Resonance Imaging Visibility in Prostate Cancer. Eur Urol. 2019 07; 76(1):18-23. Houlahan KE, Salmasi A, Sadun TY, Pooli A, Felker ER, Livingstone J, Huang V, Raman SS, Ahuja P, Sisk AE, Boutros PC, Reiter RE. PMID: 30685078; PMCID: PMC10228592.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCells
    23. PI-RADS Version 2 Category on 3 Tesla Multiparametric Prostate Magnetic Resonance Imaging Predicts Oncologic Outcomes in Gleason 3 + 4 Prostate Cancer on Biopsy. J Urol. 2019 01; 201(1):91-97. Faiena I, Salmasi A, Mendhiratta N, Markovic D, Ahuja P, Hsu W, Elashoff DA, Raman SS, Reiter RE. PMID: 30142318.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    24. PI-RADS Version 2 Category on 3 Tesla Multiparametric Prostate Magnetic Resonance Imaging Predicts Oncologic Outcomes in Gleason 3 + 4 Prostate Cancer on Biopsy. J Urol. 2019 01; 201(1):91-97. Faiena I, Salmasi A, Mendhiratta N, Markovic D, Ahuja P, Hsu W, Elashoff DA, Raman SS, Reiter RE. PMID: 30577397.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    25. Urinary Cytokine Profile to Predict Response to Intravesical BCG with or without HS-410 Therapy in Patients with Non-muscle-invasive Bladder Cancer. Cancer Epidemiol Biomarkers Prev. 2019 06; 28(6):1036-1044. Salmasi A, Elashoff DA, Guo R, Upfill-Brown A, Rosser CJ, Rose JM, Giffin LC, Gonzalez LE, Chamie K. PMID: 30593457.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    26. Detection of Individual Prostate Cancer Foci via Multiparametric Magnetic Resonance Imaging. Eur Urol. 2019 05; 75(5):712-720. Johnson DC, Raman SS, Mirak SA, Kwan L, Bajgiran AM, Hsu W, Maehara CK, Ahuja P, Faiena I, Pooli A, Salmasi A, Sisk A, Felker ER, Lu DSK, Reiter RE. PMID: 30509763.
      View in: PubMed   Mentions: 137     Fields:    Translation:Humans
    27. Variation in surgical treatment patterns for patients with prostate cancer in the United States: Do patients in academic hospitals fare better? Urol Oncol. 2019 01; 37(1):63-70. Pooli A, Salmasi A, Faiena I, Lenis AT, Johnson DC, Lebacle C, Drakaki A, Gollapudi K, Blumberg J, Pantuck AJ, Chamie K. PMID: 30446452.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    28. Treatment utilization and overall survival in patients receiving radical nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma: evaluation of updated treatment guidelines. World J Urol. 2019 Jun; 37(6):1157-1164. Upfill-Brown A, Lenis AT, Faiena I, Salmasi AH, Johnson DC, Pooli A, Drakaki A, Gollapudi K, Blumberg J, Pantuck AJ, Chamie K. PMID: 30267197; PMCID: PMC6438772.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    29. Association between renal mass biopsy and upstaging to perinephric fat involvement in a contemporary cohort of patients with clinical T1a renal cell carcinoma. Urol Oncol. 2018 12; 36(12):527.e13-527.e19. Salmasi A, Faiena I, Lenis AT, Pooli A, Johnson DC, Drakaki A, Gollapudi K, Blumberg J, Pantuck AJ, Chamie K. PMID: 30228094.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    30. Radical prostatectomy then and now: Surgical overtreatment of prostate cancer is declining from 2009 to 2016 at a tertiary referral center. Urol Oncol. 2018 09; 36(9):401.e19-401.e25. Salmasi A, Faiena I, Wu J, Sisk AE, Sachveda A, Vandel JJ, Chamie K, Marks LS, Reiter RE. PMID: 30064933.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    31. Overall survival in patients with residual disease after radical cystectomy and neoadjuvant chemotherapy. World J Urol. 2018 Nov; 36(11):1825-1833. Faiena I, Salmasi A, Mendhiratta N, Lenis AT, Pooli A, Drakaki A, Gollapudi K, Blumberg J, Pantuck AJ, Chamie K. PMID: 29752514.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    32. A 17-Gene Genomic Prostate Score Assay Provides Independent Information on Adverse Pathology in the Setting of Combined Multiparametric Magnetic Resonance Imaging Fusion Targeted and Systematic Prostate Biopsy. J Urol. 2018 09; 200(3):564-572. Salmasi A, Said J, Shindel AW, Khoshnoodi P, Felker ER, Sisk AE, Grogan T, McCullough D, Bennett J, Bailey H, Lawrence HJ, Elashoff DA, Marks LS, Raman SS, Febbo PG, Reiter RE. PMID: 29524506.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    33. Anatomic and Molecular Imaging in Prostate Cancer. Cold Spring Harb Perspect Med. 2018 03 01; 8(3). Miller ET, Salmasi A, Reiter RE. PMID: 28710256; PMCID: PMC5830905.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    34. Trends in urinary diversion after radical cystectomy for urothelial carcinoma. World J Urol. 2018 Mar; 36(3):409-416. Bachour K, Faiena I, Salmasi A, Lenis AT, Johnson DC, Pooli A, Drakaki A, Pantuck AJ, Chamie K. PMID: 29299664.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    35. Trends in usage of cytoreductive partial nephrectomy and effect on overall survival in patients with metastatic renal cell carcinoma. Urol Oncol. 2018 02; 36(2):78.e21-78.e28. Lenis AT, Salmasi AH, Donin NM, Faiena I, Johnson DC, Drakaki A, Gollapudi K, Blumberg J, Belldegrun AS, Pantuck AJ, Chamie K. PMID: 29128421.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    36. Overall survival in patients with metastatic renal cell carcinoma and clinical N1 disease undergoing cytoreductive nephrectomy and lymph node dissection. Urol Oncol. 2018 02; 36(2):79.e19-79.e26. Faiena I, Salmasi A, Lenis AT, Donin NM, Johnson DC, Bachour K, Drakaki A, Belldegrun AS, Pantuck AJ, Chamie K. PMID: 29103965.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    37. Role of surgical approach on lymph node dissection yield and survival in patients with upper tract urothelial carcinoma. Urol Oncol. 2018 01; 36(1):9.e1-9.e9. Lenis AT, Donin NM, Faiena I, Salmasi A, Johnson DC, Drakaki A, Gollapudi K, Blumberg J, Belldegrun A, Pantuck A, Chamie K. PMID: 29066013.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    38. Adrenalectomy for benign and malignant disease: utilization and outcomes by surgeon specialty and surgical approach from 2003-2013. Can J Urol. 2017 Oct; 24(5):8990-8997. Faiena I, Tabakin A, Leow J, Patel N, Modi PK, Salmasi AH, Chung BI, Chang SL, Singer EA. PMID: 28971785.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    39. Off-Target Effect of Sildenafil on Postsurgical Erectile Dysfunction: Alternate Pathways and Localized Delivery System. J Sex Med. 2016 12; 13(12):1834-1843. Salmasi A, Lee GT, Patel N, Goyal R, Dinizo M, Kwon YS, Modi PK, Faiena I, Kim HJ, Lee N, Hannan JL, Kohn J, Kim IY. PMID: 27843073.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    40. Accuracy of Multiparametric Magnetic Resonance Imaging for Extracapsular Extension of Prostate Cancer in Community Practice. Clin Genitourin Cancer. 2016 12; 14(6):e617-e622. Davis R, Salmasi A, Koprowski C, Kim S, Kwon YS, Faiena I, Patel N, Elsamra SE, Kim IY. PMID: 27188968.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    41. Effect of Uncontrolled Diabetes on Outcomes After Cystectomy in Patients With Bladder Cancer: A Population-Based Study. Clin Genitourin Cancer. 2016 10; 14(5):e509-e514. Faiena I, Dombrovskiy VY, Sultan RC, Salmasi AH, Singer EA, Weiss RE. PMID: 26997576.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    42. Oncologic outcomes in men with metastasis to the prostatic anterior fat pad lymph nodes: a multi-institution international study. BMC Urol. 2015 Aug 01; 15:79. Kwon YS, Ha YS, Modi PK, Salmasi A, Parihar JS, Patel N, Faiena I, May M, Lee DI, Llukani E, Patrick T, Rha KH, Ahlering T, Skarecky D, Ahn H, Choi SK, Park S, Jeon SS, Ou YC, Eun D, Manucha V, Albala D, Badani K, Yuh B, Ruel N, Kim TH, Kwon TG, Marchalik D, Hwang J, Kim WJ, Kim IY. PMID: 26231860; PMCID: PMC4521494.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    43. Regional Cost Variations of Robot-Assisted Radical Prostatectomy Compared With Open Radical Prostatectomy. Clin Genitourin Cancer. 2015 Oct; 13(5):447-52. Faiena I, Dombrovskiy VY, Modi PK, Patel N, Patel R, Salmasi AH, Parihar JS, Singer EA, Kim IY. PMID: 26065923; PMCID: PMC5176017.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    44. Prostate-specific antigen density toward a better cutoff to identify better candidates for active surveillance. Urology. 2014 Aug; 84(2):365-71. Ha YS, Yu J, Salmasi AH, Patel N, Parihar J, Singer EA, Kim JH, Kwon TG, Kim WJ, Kim IY. PMID: 24925834.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    45. Favorable risk factors in patients with positive surgical margin after robot-assisted radical prostatectomy. Can J Urol. 2014 Jun; 21(3):7290-7. Ha YS, Kang DI, Kim JH, Joung JY, Yu J, Parihar JS, Salmasi AH, Horie S, Kim WJ, Yi Kim I. PMID: 24978359.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    46. Concern for overtreatment using the AUA/ASTRO guideline on adjuvant radiotherapy after radical prostatectomy. BMC Urol. 2014 Apr 07; 14:30. Kang JH, Ha YS, Kim S, Yu J, Patel N, Parihar JS, Salmasi AH, Kim WJ, Kim IY. PMID: 24708639; PMCID: PMC4005471.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    47. Comprehensive analysis of sexual function outcome in prostate cancer patients after robot-assisted radical prostatectomy. J Endourol. 2014 Feb; 28(2):172-7. Woo SH, Kang DI, Ha YS, Salmasi AH, Kim JH, Lee DH, Kim WJ, Kim IY. PMID: 23987521.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    48. Increased incidence of pathologically nonorgan confined prostate cancer in African-American men eligible for active surveillance. Urology. 2013 Apr; 81(4):831-5. Ha YS, Salmasi A, Karellas M, Singer EA, Kim JH, Han M, Partin AW, Kim WJ, Lee DH, Kim IY. PMID: 23465143; PMCID: PMC3978180.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    49. Prostate screening in patients with 46,XY disorders of sex development--is it necessary? J Urol. 2008 Oct; 180(4):1422-5; discussion 1425-6. Salmasi AH, Wisniewski AB, Novak TE, Gearhart JP, Migeon CJ, Lakshmanan Y. PMID: 18710761.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    50. Protective effects of sildenafil administration on testicular torsion/detorsion damage in rats. World J Urol. 2008 Apr; 26(2):197-202. Beheshtian A, Salmasi AH, Payabvash S, Kiumehr S, Ghazinezami B, Rahimpour S, Tavangar SM, Dehpour AR. PMID: 18265987.
      View in: PubMed   Mentions: 27     Fields:    Translation:AnimalsCells
    Amirali's Networks
    Concepts (207)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (51)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version UCSF-v3.1.0-16-gff1bd585 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California